IGF::OT::IGF SEER-LINKED VIRTUAL TISSUE REPOSITORY (VTR)

美国国家癌症研究所监测、流行病学和最终结果(SEER)计划有兴趣开发一个与SEER相关的虚拟组织信息库(VTR)。具有人口代表性和大样本框架的SEER录像机将是一个独特的资源，用于收集即使是罕见肿瘤和结果的强大的生物样本集合。SEER人口统计和临床数据可以通过定制的数据注释进行扩充，包括详细的化疗、复发时间和体重指数。 录像机试点研究的目标是评估SEER登记处的能力 作为生物质学家研究的资源 在病理实验室中定位生物标本并确定取回这些生物标本的要求 提供指定数据项的自定义批注 录像机试点还将计算识别和注释这些生物标本的成本。

The National Cancer Institute Surveillance, Epidemiology and End Results (SEER) Program is interested in developing a SEER-linked Virtual Tissue Repository (VTR). A SEER VTR, with its population representativeness and large sampling frame would be a unique resource for assembling robust collections of biospecimens even for rare tumors and outcomes. SEER demographic and clinical data can be augmented with custom annotation of data including detailed chemotherapy, time to recurrence, and body mass index. The objectives of the VTR Pilot Study are to assess the ability of SEER Registries To serve as a resource for biospecimen research To locate cases with biospecimens in pathology laboratories and determine the requirements to retrieve those biospecimens To provide custom annotation of specified data items The VTR Pilot will also capture costs to identify and annotate these biospecimens.